The effect of intratympanic oxytocin treatment on rats exposed to acoustic trauma
dc.contributor.author | Akin Ocal F.C. | |
dc.contributor.author | Kesici G.G. | |
dc.contributor.author | Gurgen S.G. | |
dc.contributor.author | Ocal R. | |
dc.contributor.author | Erbek S. | |
dc.date.accessioned | 2024-07-22T08:08:36Z | |
dc.date.available | 2024-07-22T08:08:36Z | |
dc.date.issued | 2019 | |
dc.description.abstract | Objective To investigate whether oxytocin can prevent ototoxicity related to acoustic trauma.Methods Twenty-eight rats were divided into four groups: Noise (group 1), control (group 2), noise plus oxytocin (group 3), and oxytocin (group 4). Intratympanic oxytocin was administered on days 1, 2, 4, 6, 8 and 10 in groups 3 and 4. Groups 1 and 3 were exposed to acoustic trauma. Distortion product otoacoustic emission and auditory brainstem response testing were performed in all groups.Results In group 1, auditory brainstem response thresholds increased significantly after acoustic trauma. In group 3, auditory brainstem response thresholds increased significantly on day 1 after acoustic trauma, but there were no significant differences between thresholds at baseline and on the 7th and 21st days. In group 1, significant differences were observed between distortion product otoacoustic emission signal-to-noise ratios measured before and on days 1, 7 and 21 after acoustic trauma. In group 3, no significant differences were observed between the distortion product otoacoustic emission signal-to-noise ratios measured before and on days 7 and 21 after acoustic trauma.Conclusion Oxytocin had a therapeutic effect on rats exposed to acoustic trauma in this experiment. © 2019 JLO (1984) Limited. | |
dc.identifier.DOI-ID | 10.1017/S0022215119001014 | |
dc.identifier.issn | 00222151 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/14466 | |
dc.language.iso | English | |
dc.publisher | Cambridge University Press | |
dc.subject | Animals | |
dc.subject | Biopsy, Needle | |
dc.subject | Disease Models, Animal | |
dc.subject | Evoked Potentials, Auditory, Brain Stem | |
dc.subject | Hearing Loss, Noise-Induced | |
dc.subject | Immunohistochemistry | |
dc.subject | Injections, Intralesional | |
dc.subject | Male | |
dc.subject | Otoacoustic Emissions, Spontaneous | |
dc.subject | Oxytocin | |
dc.subject | Random Allocation | |
dc.subject | Rats | |
dc.subject | Rats, Sprague-Dawley | |
dc.subject | Reference Values | |
dc.subject | Signal-To-Noise Ratio | |
dc.subject | Statistics, Nonparametric | |
dc.subject | Treatment Outcome | |
dc.subject | Tympanic Membrane | |
dc.subject | oxytocin | |
dc.subject | synpitan fort | |
dc.subject | oxytocin | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | animal tissue | |
dc.subject | Article | |
dc.subject | auditory response | |
dc.subject | brain stem response | |
dc.subject | cochlea tissue | |
dc.subject | controlled study | |
dc.subject | distortion product otoacoustic emission | |
dc.subject | external auditory canal | |
dc.subject | immunohistochemistry | |
dc.subject | male | |
dc.subject | noise injury | |
dc.subject | nonhuman | |
dc.subject | ototoxicity | |
dc.subject | rat | |
dc.subject | signal noise ratio | |
dc.subject | therapy effect | |
dc.subject | white noise | |
dc.subject | animal | |
dc.subject | comparative study | |
dc.subject | disease model | |
dc.subject | drug effect | |
dc.subject | eardrum | |
dc.subject | evoked brain stem auditory response | |
dc.subject | intralesional drug administration | |
dc.subject | needle biopsy | |
dc.subject | noise injury | |
dc.subject | nonparametric test | |
dc.subject | pathology | |
dc.subject | randomization | |
dc.subject | reference value | |
dc.subject | spontaneous otoacoustic emission | |
dc.subject | Sprague Dawley rat | |
dc.subject | treatment outcome | |
dc.title | The effect of intratympanic oxytocin treatment on rats exposed to acoustic trauma | |
dc.type | Article |